In terms of disease diagnosis, there is no apparent correlation between the location of mutations on the RyR2 structure and the clinical phenotype presenting as typical or atypical CPVT. The gene discussed is RYR2; the disease is catecholaminergic polymorphic ventricular tachycardia.